/LITH

LITH Stock - BioELife Corp.

Q: What is the analyst price target for LITH?

Analyst price target information is not currently available for LITH.

Q: What is LITH's market cap?

Market capitalization information is not currently available for LITH.

Healthcare|Drug Manufacturers - Specialty & Generic|OTC

$0.00+0.00%

+$0.00 (+0.00%) • Dec 19

GoAI Score

Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.

BUY

Medium Confidence

Momentum

Momentum Score

Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.

100

Sentiment

Sentiment Score

Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).

Risk Score

Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.

Price Target

Average analyst price target from the last quarter. Shows expected upside/downside from current price.

+10.0%upside

Target: $0.00

AI Analysis PreviewPremium

Real-time AI-powered market analysis

Precise entry/exit price targets

Risk assessment & position sizing

Unlock GoAI Insights for LITH

Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.

Buy/Sell Signals

94% win rate on Alpha signals

Deep Analysis

Institutional-grade thesis

Real-Time Alerts

SMS & push notifications

Risk Scoring

Multi-factor analysis

Free 14-day trial • No credit card required

Financial Statements

Revenue & Profitability Trend

FY2014

FY2015

FY2016

FY2017

FY2018

← Swipe to see more →

Revenue

Net Income (Profit)

Net Loss

Key Metrics

Market CapN/A

P/E RatioN/A

Beta1.50

52W High$0.00

52W Low$0.00

Avg VolumeN/A

Income Statement (Fiscal Year)

Metric	FY2018	FY2017	FY2016	FY2015	FY2014
Revenue	N/A	N/A	N/A	N/A	N/A
Gross Profit	$-800	$-800	$-1,775	N/A	$-396,000
Gross Margin	N/A	N/A	N/A	N/A	N/A
Operating Income	$-73,743	$-125,000	$-104,000	$-61,352	$-464,000
Net Income	$-336,958	$-247,000	$-210,000	$-82,187	$-498,000
Net Margin	N/A	N/A	N/A	N/A	N/A
EPS	$-0.13	$-0.10	$-0.09	$-0.04	$-0.44

Company Overview

BioELife Corp. operates in cannabinoid market. It offers cannabinoid products, such as combo adult gummies with chirorub, combo tincture with chirorub, intensive relief rub, tinctures, adult gummies, premium pre-rolls, and flowers. The company was formerly known as US Lithium Corp. and changed its name to BioELife Corp. in March 2020. The company was founded in 2006 and is based in Seal Beach, California.

Visit Website

Frequently Asked Questions about LITH

What is LITH's current stock price?

BioELife Corp. (LITH) is currently trading at $0.00 per share. The stock has moved +0.00% today.

What is the analyst price target for LITH?

No analyst price targets are currently available for this stock.

What sector is BioELife Corp. in?

BioELife Corp. operates in the Healthcare sector, specifically within the Drug Manufacturers - Specialty & Generic industry. The company is traded on the OTC exchange.

What is LITH's market cap?

BioELife Corp. has a market capitalization of $0.00 billion, making it a small-cap company.

Does LITH pay dividends?

No, BioELife Corp. does not currently pay a dividend to shareholders.